Uday Kompella
Founder at OCUGEN, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Uday B.
Kompella is a Director & Chief Scientific Officer, Independent Director, and Director at Ocugen, Inc. and Ocugen OpCo, Inc. respectively, both founded in 2013.
He is also a Professor-Pharmaceutical Sciences at CU Anschutz Medical Campus.
Dr. Kompella holds a doctorate from the University of Southern California, an undergraduate degree from Birla Institute of Technology & Science, and a graduate degree from Jadavpur University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCUGEN INC
0.27% | 08/06/2023 | 705,090 ( 0.27% ) | 1 M $ | 30/03/2024 |
Uday Kompella active positions
| Companies | Position | Start |
|---|---|---|
| OCUGEN, INC. | Founder | 31/12/2012 |
| Ocugen OpCo, Inc. | Founder | 31/08/2013 |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - |
Former positions of Uday Kompella
| Companies | Position | End |
|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Founder | - |
Training of Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Stock Market
- Insiders
- Uday Kompella
